pharma stocks

Axxess Pharma Inc (OTCMKTS:AXXE) Surges On FDA Approval

In mid-January, the share price of Axxess Pharma Inc (OTCMKTS:AXXE) crossed 21 cents a share. However, in last week the stock posted lowest close of almost $0.062 per share, indicating a 70% loss in less than three months.

The developments

Since the start of 2015, Axxess has reported strong developments on its operations front. First it received a first purchase order from Thailand and then it received second order from Hardcore Beverages in the first week of March. Despite the developments and positive press releases, Axxess Pharma Inc (OTCMKTS:AXXE) stock failed to stop its crash down the chart.

The turnaround

What the positive press releases failed to do was done by the latest announcement of the company. Axxess Pharma announced that it received an approval from the U.S. FDA to sell several of its products including Muscle Recovery Supplements, Turbo Blend Protein powders, Omega-3 fish oil and Muscle growth supplements. After the news, the company’s stock not only reversed their downtrend but did in a spectacular way. The prices opened with a gap up and then surged more than 67% to close at $0.161. Investors also showed interest in AXXE stock with more than 6.33 million shares changing hands.

The other news

The large move in Axxess Pharma stock was also facilitated through another press release issued by a firm called DailyStockReporter. The entity provided an upbeat description of Axxess Pharma but as always before investors get too invested in words it may be for their good to consider the disclaimer published on their official website. There they can find the statement that they only report favorable information as they are compensated for the same purpose. It has been paid on two occasions to highlight positive aspects of Axxess Pharma. First they received $15,000 in September 2014 and the second time they were paid$45,000 in January. The company has been touted by a number of paid pumpers for almost two years now.

Related News

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyrıght 2015 All RIGHTS RESERVED.